2007 Press Releases

DateTitle 
November 28, 2007POZEN to Present at the RBC Capital Markets 2007 Healthcare ConferencePrinter Friendly Version
November 26, 2007POZEN To Present at the BMO Capital Markets 2007 Focus on Healthcare ConferencePrinter Friendly Version
November 14, 2007POZEN To Present at the Lazard Capital Markets Fourth Annual Healthcare ConferencePrinter Friendly Version
November 01, 2007POZEN Reports Third Quarter ResultsPrinter Friendly Version
November 01, 2007Pozen Announces Trexima(TM) (Sumatriptan Succinate and Naproxen Sodium) Amended Response Accepted for Review by FDAPrinter Friendly Version
October 17, 2007POZEN Announces November 1, 2007 Webcast of Third Quarter 2007 ResultsPrinter Friendly Version
October 15, 2007POZEN Submits Response to Approvable Letter for Trexima(TM)Printer Friendly Version
October 05, 2007POZEN Plans to Submit Response to Approvable Letter For Trexima(TM) Within the Next Ten DaysPrinter Friendly Version
September 07, 2007POZEN Announces September 7, 2007 WebcastPrinter Friendly Version
September 07, 2007POZEN/AstraZeneca Announce Start of the PN 400 Phase III ProgramPrinter Friendly Version
August 02, 2007Pozen Announces August 2, 2007, WebcastPrinter Friendly Version
August 02, 2007FDA Issues Second Approvable Letter for Trexima (TM)Printer Friendly Version
July 26, 2007POZEN Reports Second Quarter 2007 ResultsPrinter Friendly Version
July 24, 2007POZEN Names Dr. John G. Fort as Chief Medical OfficerPrinter Friendly Version
July 16, 2007POZEN Announces July 26, 2007 Webcast of Second Quarter 2007 ResultsPrinter Friendly Version
July 10, 2007POZEN Announces Settlement Agreement in Shareholder LawsuitPrinter Friendly Version
June 14, 2007POZEN to Present at the Jefferies 2007 Healthcare ConferencePrinter Friendly Version
May 31, 2007POZEN to Present at the Needham Sixth Annual Biotechnology & Medical Technology ConferencePrinter Friendly Version
May 14, 2007POZEN To Present at Citigroup's Global Healthcare ConferencePrinter Friendly Version
May 02, 2007POZEN Reports First Quarter 2007 ResultsPrinter Friendly Version
May 01, 2007POZEN to Present at the Baird 2007 Growth Stock ConferencePrinter Friendly Version
April 30, 2007POZEN To Present at the 2007 UBS Global Generic and Specialty Pharmaceuticals ConferencePrinter Friendly Version
April 18, 2007POZEN Announces May 2, 2007 Webcast of First Quarter 2007 ResultsPrinter Friendly Version
April 03, 2007Trexima (TM) (Sumatriptan/Naproxen Sodium) Superior Efficacy Data Published in JAMAPrinter Friendly Version
March 22, 2007POZEN Announces Trexima(TM) (Sumatriptan Succinate and Naproxen Sodium) Amended Response Accepted for Review by FDAPrinter Friendly Version
March 12, 2007POZEN to Present at the 27th Annual Cowen & Company Healthcare ConferencePrinter Friendly Version
March 07, 2007POZEN Reports Fourth Quarter and Year End 2006 ResultsPrinter Friendly Version
March 06, 2007POZEN Announces Positive Outcome for PA 325 Proof of Concept StudyPrinter Friendly Version
February 28, 2007POZEN To Present at the Oppenheimer Conference ''Positioning Investors for the Next Wave in Pain Management''Printer Friendly Version
February 16, 2007POZEN To Present at the Susquehanna Financial Group Healthcare ConferencePrinter Friendly Version
February 15, 2007Jacques Rejeange Appointed to POZEN Board of DirectorsPrinter Friendly Version
February 14, 2007POZEN Announces March 7 Webcast of Fourth Quarter and Full Year 2006 ResultsPrinter Friendly Version
January 17, 2007POZEN to Present at the Wachovia Securities 2007 Small and Mid-Cap Healthcare ConferencePrinter Friendly Version
January 10, 2007POZEN Names Gilda M. Thomas as Senior Vice President and General CounselPrinter Friendly Version

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.